We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Increased cross-presentation by dendritic cells and enhanced anti-tumour therapy using the Arp2/3 inhibitor CK666

    Background

    Dendritic cell (DC) vaccines for cancer therapy offer the possibility to let the patient’s own immune system kill cancer cells. However, DC...

    Mariana M. S. Oliveira, Roberta D’Aulerio, ... Lisa S. Westerberg in British Journal of Cancer
    Article Open access 11 January 2023
  2. Perforin 2 mediates endosomal antigen export for cross-presentation

    Aljawharah Alrubayyi, Sarah Rowland-Jones in Nature Reviews Immunology
    Article 03 May 2023
  3. Anticipated time to seek medical advice for possible lung cancer symptoms and barriers to timely presentation in Palestine: a national cross-sectional study

    Background

    Lung cancer (LC) has poor survival outcomes mainly due to diagnosis at late stages. This study explored the anticipated time to seek...

    Mohamedraed Elshami, Nawras Sawafta, ... Nasser Abu-El-Noor in BMC Cancer
    Article Open access 07 February 2024
  4. Anticipated time to seek medical advice for possible ovarian cancer symptoms and perceived barriers to early presentation among Palestinian women: a national cross-sectional study

    Background

    Several factors contribute to delayed presentation with ovarian cancer (OC) symptoms including poor symptom awareness and barriers to...

    Mohamedraed Elshami, Sondos Al-Madhoun, ... Bettina Bottcher in BMC Cancer
    Article Open access 13 October 2023
  5. Hematological, clinical, cytogenetic and molecular profiles of confirmed chronic myeloid leukemia patients at presentation at a tertiary care teaching hospital in Addis Ababa, Ethiopia: a cross-sectional study

    Background

    In low-income countries there is insufficient evidence on hematological, clinical, cytogenetic and molecular profiles among new CML...

    Fekadu Urgessa, Boki Lengiso, ... Teklu Kuru Gerbaba in BMC Cancer
    Article Open access 26 April 2024
  6. TAP dysfunction in dendritic cells enables noncanonical cross-presentation for T cell priming

    Classic major histocompatibility complex class I (MHC-I) presentation relies on shuttling cytosolic peptides into the endoplasmic reticulum (ER) by...

    Gaëtan Barbet, Priyanka Nair-Gupta, ... J. Magarian Blander in Nature Immunology
    Article 31 March 2021
  7. Frequency of viral infections in adolescent and adult in-patient Ethiopians with acute leukemia at presentation to a tertiary care teaching hospital: a cross-sectional study

    Background

    Leukemic patients are prone to infectious agents such as viruses due to dysregulated immune system resulting from infiltration of the bone...

    Jemal Alemu, Balako Gumi, ... Rawleigh Howe in Infectious Agents and Cancer
    Article Open access 12 July 2023
  8. Cross-presentation is getting DNGRous

    Remi Hatinguais, Gordon D. Brown in Nature Immunology
    Article 04 January 2021
  9. Prevalence of late-stage presentation and associated factors of cervical cancer patients in Tikur Anbesa Specialized Hospital, Ethiopia: institutional based cross-sectional study

    Background

    Cancer of the uterine cervix remains a main public health problem in Sub-Saharan Africa. About two-thirds of patients with cervical cancer...

    Mulugeta Wassie, Beletech Fentie in Infectious Agents and Cancer
    Article Open access 11 May 2021
  10. The receptor DNGR-1 signals for phagosomal rupture to promote cross-presentation of dead-cell-associated antigens

    Type 1 conventional dendritic (cDC1) cells are necessary for cross-presentation of many viral and tumor antigens to CD8 + T cells. cDC1 cells can be...

    Johnathan Canton, Hanna Blees, ... Caetano Reis e Sousa in Nature Immunology
    Article 21 December 2020
  11. Publisher Correction: The receptor DNGR-1 signals for phagosomal rupture to promote cross-presentation of dead-cell-associated antigens

    A Correction to this paper has been published: https://doi.org/10.1038/s41590-021-00885-6.

    Johnathan Canton, Hanna Blees, ... Caetano Reis e Sousa in Nature Immunology
    Article 02 February 2021
  12. FcRn regulates antigen presentation in dendritic cells downstream of DEC205-targeted vaccines

    Dendritic cell (DC)-targeted vaccination is a new mode of antigen delivery that relies on the use of monoclonal antibodies (mAb) to target antigen to...

    Christophe Macri, Matthew Paxman, ... Justine D. Mintern in npj Vaccines
    Article Open access 09 April 2024
  13. Advanced-stage presentation of cancer at the time of diagnosis and its associated factors among adult cancer patients at Northwest Amhara comprehensive specialized hospitals, Northwest Ethiopia 2022

    Introduction

    Screening of cancer is the maximum effort and critical element for providing health related care in order to decrease cancer related...

    Likinaw Abebaw Wassie, Chilot Kassa Mekonnen, ... Alebachew Ferede Zegeye in BMC Cancer
    Article Open access 12 January 2024
  14. Prostate cancer in New York City: impact of neighborhood level social determinants of care

    Social determinants of health may impact prostate cancer presentation. Since neighborhoods may influence adjacent neighborhoods across often porous...

    Justin Chestang, Shikun Wang, James B. Yu in Prostate Cancer and Prostatic Diseases
    Article 30 June 2023
  15. Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages

    A growing body of evidence supports the importance of T cell responses to protect against severe influenza, promote viral clearance, and ensure...

    Alexander I. Makarkov, Makan Golizeh, ... Brian J. Ward in npj Vaccines
    Article Open access 15 May 2019
  16. Tissue-resident memory T cells break tolerance to renal autoantigens and orchestrate immune-mediated nephritis

    Immune-mediated nephritis is a leading cause of acute kidney injury and chronic kidney disease. While the role of B cells and antibodies has been...

    Frederic Arnold, Laurence Kupferschmid, ... Yakup Tanriver in Cellular & Molecular Immunology
    Article Open access 03 July 2024
  17. Immunization against Zika by entrap** live virus in a subcutaneous self-adjuvanting hydrogel

    The threat of new viral outbreaks has heightened the need for ready-to-use vaccines that are safe and effective. Here we show that a subcutaneous...

    Haibin Hao, Shipo Wu, ... Ruikang Tang in Nature Biomedical Engineering
    Article 23 March 2023
  18. Association of Sport Helmet Status on Concussion Presentation and Recovery in Male Collegiate Student-Athletes

    Sporting helmets contain force attenuating materials which reduce traumatic head injury risk and may influence sport-related concussion (SRC)...

    Adrian J. Boltz, Landon B. Lempke, ... Alison Brooks in Annals of Biomedical Engineering
    Article 08 July 2024
  19. Neutralizing Antibody Sample Testing and Report Harmonization

    Immunogenicity testing and characterization is an important part of understanding the immune response to administration of a protein therapeutic....

    Darshana Jani, Michele Gunsior, ... Lin Yang in The AAPS Journal
    Article Open access 12 July 2024
  20. A systematic safety pipeline for selection of T-cell receptors to enter clinical use

    Cancer immunotherapy using T cell receptor-engineered T cells (TCR-Ts) represents a promising treatment option. However, technologies for...

    Zsofia Foldvari, Cathrine Knetter, ... Johanna Olweus in npj Vaccines
    Article Open access 22 August 2023
Did you find what you were looking for? Share feedback.